ロード中...
Determinants of Survival in Advanced Non-Small Cell Lung Cancer (NSCLC) in the Era of Targeted Therapies
INTRODUCTION: Molecular profiling of NSCLC samples has a profound impact on choice of therapy. It is less clear, however, whether EGFR and KRAS mutations are prognostic outside of a trial-based treatment paradigm. METHODS: We performed a retrospective chart review of 513 NSCLC patients undergoing EG...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3762923/ https://ncbi.nlm.nih.gov/pubmed/23827517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.05.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|